GlassScriptPhysician profile
Michael G Waters
NPI 1275596538
$27,272.44
in general payments reported to CMS, 2019-2025
59 companies · $2,953 in 2025
The $2,953 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,521 · 2020: $2,200 · 2021: $4,270 · 2022: $6,211 · 2023: $4,346 · 2024: $3,771 · 2025: $2,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,281 · Travel and Lodging: $1,431 · Education: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,280.74 |
| Travel and Lodging | $1,431.07 |
| Education | $357.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,249.21 | 2021-2025 | Interstim |
| Coloplast Corp | $3,134.02 | 2019-2025 | Titan, Altis, Speedicath |
| Angiodynamics, INC. | $2,566.81 | 2023-2025 | Nanoknife |
| Teleflex LLC | $1,887.99 | 2021-2025 | Barrigel, Urolift |
| Axonics, INC. | $1,705.56 | 2020-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $1,648.47 | 2019-2025 | Erleada, Akeega, Carvykti |
| Neotract INC. | $1,277.84 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $1,010.97 | 2020-2025 | Provenge |
| Medtronic USA, INC. | $905.85 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $904.22 | 2019-2024 | Xiaflex, Aveed, Edex |
| Valencia Technologies Corporation | $817.39 | 2022-2025 | Ecoin Device Kit |
| Astellas Pharma US INC | $692.47 | 2019-2024 | Veozah |
| Uromedica, Incorporated | $613.24 | 2020-2021 | |
| Abbvie INC. | $521.31 | 2020-2024 | |
| Boston Scientific Corporation | $516.25 | 2019-2025 | Rezum Generator, Lithovue, Spaceoar Vue System - 10ml |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $508.23 | 2023-2025 | Orgovyx, Gemtesa |
| Rochester Medical Corporation | $391.87 | 2022 | |
| Olympus America INC. | $301.61 | 2019-2025 | Itind System |
| Urogen Pharma, INC. | $277.48 | 2021-2025 | |
| Pfizer INC. | $272.66 | 2022-2025 | |
| Johnson & Johnson Health Care Systems INC. | $261.15 | 2024-2025 | Darzalex, Stelara |
| Innovation Technologies INC | $254.00 | 2022-2024 | Irrisept |
| Allergan, INC. | $237.65 | 2019 | |
| Antares Pharma, INC. | $197.11 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| 180 Medical, INC. | $191.04 | 2021-2023 | Gentlecath |
| Procept Biorobotics Corporation | $187.83 | 2021-2025 | Aquabeam System |
| Endo USA, INC. | $181.23 | 2024-2025 | Xiaflex, Aveed |
| Urovant Sciences INC | $161.31 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $156.75 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $145.63 | 2019-2024 | |
| Olympus Corporation of The Americas | $142.10 | 2023 | Itind System |
| Avation Medical, INC. | $139.92 | 2025 | Vivally System |
| Bard Access Systems, INC. | $135.76 | 2019 | |
| Accord Healthcare, INC. | $134.72 | 2022-2025 | |
| Clarus Therapeutics INC. | $124.99 | 2021 | |
| Verity Pharmaceuticals INC. | $117.77 | 2024-2025 | Trelstar, Tlando |
| Myovant Sciences INC. | $114.56 | 2021-2022 | |
| Bk Medical Holding Company INC. | $100.59 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Agiliti Surgical, INC. | $98.15 | 2021-2023 | Sonablate |
| Agiliti Health, INC. | $97.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.97 | 2021-2025 | |
| Tolmar Pharmaceuticals, INC. | $83.39 | 2021-2022 | |
| Tolmar, INC. | $77.58 | 2023-2025 | Jatenzo, Eligard |
| Mission Pharmacal Company | $73.88 | 2019-2024 | Uribel Tabs |
| Ferring Pharmaceuticals INC. | $70.56 | 2019-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $63.22 | 2023-2024 | Pylarify |
| Myriad Genetic Laboratories, INC. | $50.21 | 2022-2025 | Prolaris |
| Uc-Care (USA), INC | $49.03 | 2025 | Navigo Workstation |
| Azurity Pharmaceuticals, INC. | $42.37 | 2025 | Azmiro |
| Halozyme INC | $42.18 | 2023 | |
| Ambu INC. | $42.02 | 2024 | |
| Travere Therapeutics, INC. | $39.70 | 2022 | |
| Ethicon US, LLC | $32.59 | 2025 | Surgiflo Hemostatic Matrix |
| Healthtronics Stone Solutions, LLC | $29.21 | 2020 | |
| Bluewind Medical | $27.00 | 2024 | |
| Cycle Pharmaceuticals INC | $21.84 | 2025 | Venxxiva |
| Vertex Pharmaceuticals Incorporated | $20.87 | 2025 | |
| Hollister Incorporated | $19.39 | 2022 | |
| Kerecis Limited | $19.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.